Non-CHO cell expression systems gain traction as faster, more flexible alternatives for biologics manufacturing.

University of Edinburgh spin-out BIOCAPTIVA secures £1.58m funding and launches its msX liquid biopsy technology in the US to improve cancer diagnostics and research.

About three decades ago, an idea of scientists recreating dinosaurs first exploded into the public with the 1993 blockbuster ...

This manuscript describing the phenotypes associated with loss and gain of RVCL-S documents important findings that have practical implications. Although the data and methods are solid and support ...

A viral social media exchange involving Elon Musk has revived debate about whether science could one day recreate extinct ...

Researchers at the University of Illinois and partner institutions created the first soybean cyst nematode pangenome. The post Scientists map soybean cyst nematode pangenome to fight $1.5B pest ...

Few pests eat away at farm profitability as much as soybean cyst nematode (SCN). Causing at least $1.5 billion in yield losses annually, it's soybean's single biggest threat. Unfortunately, soybean's ...

Few pests eat away at farm profitability as much as soybean cyst nematode (SCN). Causing at least $1.5 billion in yield losses ...

Hepion Pharmaceuticals, Inc. (OTCQB:HEPA), a precision diagnostics company, today announced that it has in-licensed from ...

Next-generation, non-invasive diagnostic platform has potential applications in solid tumor types beyond liver cancer Licensing deal reflects Hepion's strategic shift to advancing clinically proven li ...

Few pests eat away at farm profitability as much as soybean cyst nematode (SCN). Causing at least $1.5 billion in yield losses annually, it’s soybean’s single biggest threat. Unfortunately, soybean’s ...

New research has found that at-home gut microbiome tests lack standardization, resulting in different results from the same ...